STUDIES ON BLOOD COAGULATION: A PROTEOLYTIC ENZYME PREPARED FROM CALCIUM AND PLATELET FREE NORMAL HUMAN BLOOD PLASMA.
作者信息
Tagnon H J, Davidson C S, Taylor F H
机构信息
Thorndike Memorial Laboratory, Second and Fourth Medical Services (Harvard), Boston City Hospital, Boston.
出版信息
J Clin Invest. 1942 Sep;21(5):525-31. doi: 10.1172/JCI101329.
Abstract
摘要
相似文献
1
STUDIES ON BLOOD COAGULATION: A PROTEOLYTIC ENZYME PREPARED FROM CALCIUM AND PLATELET FREE NORMAL HUMAN BLOOD PLASMA.血液凝固研究：一种从不含钙和血小板的正常人血浆中制备的蛋白水解酶。
J Clin Invest. 1942 Sep;21(5):525-31. doi: 10.1172/JCI101329.
2
Studies on a proteolytic enzyme in human plasma; the relationship between the proteolytic activity of plasma and blood coagulation.人体血浆中一种蛋白水解酶的研究；血浆蛋白水解活性与血液凝固之间的关系。
J Exp Med. 1950 Feb;91(2):123-33. doi: 10.1084/jem.91.2.123.
3
The role of platelets in blood coagulation--effects of platelet agonists and GPIIb/IIIa inhibitors studied by free oscillation rheometry.血小板在血液凝固中的作用——通过自由振荡流变学研究血小板激动剂和糖蛋白IIb/IIIa抑制剂的作用
Thromb Res. 2002 Jan 15;105(2):165-72. doi: 10.1016/s0049-3848(02)00005-1.
4
Surface-governed molecular regulation of blood coagulation.血液凝固的表面调控分子机制
Mol Aspects Med. 1983;6(4):291-353. doi: 10.1016/0098-2997(83)90002-x.
5
Studies on a proteolytic enzyme in human plasma. VIII. The effect of calcium and strontium ions on the activation of the plasma proteolytic enzyme.人体血浆中一种蛋白水解酶的研究。VIII. 钙离子和锶离子对血浆蛋白水解酶激活的影响。
J Exp Med. 1952 May;95(5):319-29. doi: 10.1084/jem.96.4.319.
6
The anticoagulant effect of the human secretory phospholipase A2 on blood plasma and on a cell-free system is due to a phospholipid-independent mechanism of action involving the inhibition of factor Va.人分泌型磷脂酶A2对血浆和无细胞系统的抗凝作用归因于一种不依赖磷脂的作用机制，该机制涉及对因子Va的抑制。
Eur J Biochem. 1996 May 1;237(3):778-85. doi: 10.1111/j.1432-1033.1996.0778p.x.
7
Direct activation of platelets by addition of CaCl leads coagulation of platelet-rich plasma.通过添加氯化钙直接激活血小板会导致富含血小板血浆的凝固。
Int J Implant Dent. 2018 Aug 1;4(1):23. doi: 10.1186/s40729-018-0134-6.
8
A new plasma-adapted hydroxyethyl starch preparation: in vitro coagulation studies.一种新型的适应血浆的羟乙基淀粉制剂：体外凝血研究。
J Cardiothorac Vasc Anesth. 2010 Jun;24(3):394-8. doi: 10.1053/j.jvca.2009.09.014. Epub 2009 Dec 11.
9
引用本文的文献
1
ACTIVATION OF PROPLASMIN BY A FACTOR FROM MAMMALIAN TISSUE.来自哺乳动物组织的一种因子对纤溶酶原的激活作用。
J Clin Invest. 1950 Mar;29(3):317-24. doi: 10.1172/JCI102260.
2
STUDIES ON THE ACTIVATION OF A SERUM "PROTHROMBIN-CONVERTING FACTOR".血清“凝血酶原转化因子”激活的研究
J Clin Invest. 1949 May;28(3):492-504. doi: 10.1172/JCI102096.
3
EFFECT OF BLOOD PROTEASE AND TRYPSIN INHIBITOR ON THE CLOTTING MECHANISM.血液蛋白酶和胰蛋白酶抑制剂对凝血机制的影响
J Clin Invest. 1947 May;26(3):364-9. doi: 10.1172/JCI101818.
4
STUDIES OF STREPTOCOCCAL FIBRINOLYSIS. II. THE INHIBITION OF STREPTOCOCCAL FIBRINOLYSIS BY ANTIFIBRINOLYSIN AND ANTIPROTEASE.链球菌纤维蛋白溶解研究。II. 抗纤维蛋白溶解素和抗蛋白酶对链球菌纤维蛋白溶解的抑制作用
J Clin Invest. 1946 May;25(3):337-46. doi: 10.1172/JCI101714.
5
STUDIES OF STREPTOCOCCAL FIBRINOLYSIS. I. THE DISSIMILARITY OF SERUM PROTEASE AND TRYPSIN AS INDICATED BY THE SEPARATE SPECIFICITIES OF THEIR KINASES, FIBRINOLYSIN AND ENTEROKINASE.链球菌纤维蛋白溶解研究。I. 血清蛋白酶与胰蛋白酶的差异，由其激酶、纤维蛋白溶酶和肠激酶的不同特异性表明
J Clin Invest. 1946 May;25(3):331-6. doi: 10.1172/JCI101713.
6
STUDIES IN BLOOD COAGULATION: THE COAGULATION PROPERTIES OF CERTAIN GLOBULIN FRACTIONS OF NORMAL HUMAN PLASMA IN VITRO.血液凝固研究：正常人血浆某些球蛋白组分在体外的凝固特性
J Clin Invest. 1945 Sep;24(5):698-703. doi: 10.1172/JCI101653.
7
CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. XV. THE PROTEINS CONCERNED IN THE BLOOD COAGULATION MECHANISM.人血浆成分制品的化学、临床及免疫学研究。十五、血液凝固机制相关蛋白质
J Clin Invest. 1944 Jul;23(4):557-65. doi: 10.1172/JCI101522.
8
PRESERVATION OF NORMAL HUMAN PLASMA IN THE LIQUID STATE. III. STUDIES ON CHEMICAL AND PHYSICO-CHEMICAL CHANGES DURING THE SECOND YEAR OF STORAGE.液态保存正常人血浆。III. 储存第二年期间的化学及物理化学变化研究
J Clin Invest. 1944 May;23(3):357-60. doi: 10.1172/JCI101502.
9
THE COAGULATION DEFECT IN HEMOPHILIA: A COMPARISON OF THE PROTEOLYTIC ACTIVITY OF CHLOROFORM PREPARATIONS OF HEMOPHILIC AND NORMAL HUMAN PLASMA.血友病中的凝血缺陷：血友病患者与正常人血浆氯仿制剂的蛋白水解活性比较。
J Clin Invest. 1943 Jan;22(1):127-9. doi: 10.1172/JCI101363.
10
STUDIES ON BLOOD COAGULATION: THE NATURE AND PROPERTIES OF A PROTEOLYTIC ENZYME DERIVED FROM PLASMA.血液凝固研究：源自血浆的一种蛋白水解酶的性质与特性
J Clin Invest. 1942 Sep;21(5):533-7. doi: 10.1172/JCI101330.
本文引用的文献
1
THE SIGNIFICANCE OF FIBRINOLYSIS IN THE MECHANISM OF COAGULATION OF BLOOD.纤维蛋白溶解在血液凝固机制中的意义
Science. 1942 Mar 27;95(2465):334. doi: 10.1126/science.95.2465.334.
2
STUDIES ON BLOOD COAGULATION: THE NATURE AND PROPERTIES OF A PROTEOLYTIC ENZYME DERIVED FROM PLASMA.血液凝固研究：源自血浆的一种蛋白水解酶的性质与特性
J Clin Invest. 1942 Sep;21(5):533-7. doi: 10.1172/JCI101330.
3
THE COAGULATION DEFECT IN HEMOPHILIA: STUDIES OF THE CLOT PROMOTING ACTIVITY ASSOCIATED WITH PLASMA EUGLOBULIN IN HEMOPHILIA.血友病中的凝血缺陷：血友病患者血浆优球蛋白相关促凝活性的研究
J Clin Invest. 1939 Nov;18(6):821-5. doi: 10.1172/JCI101099.
4
THE COAGULATION DEFECT IN HEMOPHILIA: THE CLOT PROMOTING ACTIVITY IN HEMOPHILIA OF BERKEFELDED NORMAL HUMAN PLASMA FREE FROM FIBRINOGEN AND PROTHROMBIN.血友病中的凝血缺陷：不含纤维蛋白原和凝血酶原的伯克费尔德正常人血浆在血友病中的促凝活性。
J Clin Invest. 1939 Sep;18(5):603-8. doi: 10.1172/JCI101074.
5
HEMOPHILIA. II. SOME PROPERTIES OF A SUBSTANCE OBTAINED FROM NORMAL HUMAN PLASMA EFFECTIVE IN ACCELERATING THE COAGULATION OF HEMOPHILIC BLOOD.血友病。二、从正常人血浆中提取的一种物质的某些特性，该物质能有效加速血友病患者血液的凝固。
J Clin Invest. 1937 Jan;16(1):113-24. doi: 10.1172/JCI100829.
Zotero 插件